Australia markets closed

Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.70-0.28 (-4.01%)
At close: 04:00PM EDT
6.40 -0.30 (-4.48%)
After hours: 05:43PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.98
Open6.95
Bid6.67 x 400
Ask6.69 x 400
Day's range6.67 - 7.11
52-week range4.07 - 21.05
Volume697,848
Avg. volume1,353,577
Market cap423.703M
Beta (5Y monthly)1.65
PE ratio (TTM)N/A
EPS (TTM)-0.18
Earnings date19 June 2024 - 24 June 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est12.25
  • GlobeNewswire

    Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

    TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today it received a notice (the “Notice”) on March 19, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure t

  • GuruFocus.com

    Avid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial Results

    Insights into Revenue, Gross Profit, and Operational Performance

  • GlobeNewswire

    Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

    TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029 (the “2029 Notes”). In connection with the offering, the company entered into private placement purchase agreements with the several purchasers, each of whom is a “qualified institutional buyer” within the meaning o